• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

能够控制共研磨β-拉帕醌溶解行为的机械坚固的胃滞留给药系统。

Mechanically Robust Gastroretentive Drug-Delivery Systems Capable of Controlling Dissolution Behaviors of Coground β-Lapachone.

作者信息

Kim Hyeongmin, Lee Chung-Lyol, Lee Seohyun, Lee Tae Jin, Haleem Iqra, Lee Younghong, Hwang Na Jung, Shim Kyusun, Kim Dohyun, Lee Jaehwi

机构信息

College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.

出版信息

Pharmaceutics. 2019 Jun 10;11(6):271. doi: 10.3390/pharmaceutics11060271.

DOI:10.3390/pharmaceutics11060271
PMID:31185692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6630442/
Abstract

In this study, we aimed to design a highly swellable and mechanically robust matrix tablet (SMT) as a gastroretentive drug-delivery system (GRDDS) capable of improving the dissolution behavior of β-lapachone with low aqueous solubility. For the preparation of SMTs, the cogrinding technique and freeze-thaw method were used to disperse β-lapachone in SMTs in an amorphous state and to enhance the swelling and mechanical properties of SMTs, respectively. As a result, the crystallinity of coground β-lapachone incorporated in the SMTs was found to be considerably decreased; thereby, the dissolution rates of the drug in a simulated gastric fluid could be substantially increased. The SMTs of β-lapachone also demonstrated significantly enhanced swelling and mechanical properties compared to those of a marketed product. The reason for this might be because the physically crosslinked polymeric networks with a porous structure that were formed in SMTs through the freeze-thaw method. In addition, β-lapachone was gradually released from the SMTs in 6 h. Therefore, SMTs of β-lapachone developed in this study could be used as GRDDS with appropriate swelling and mechanical properties for improving the dissolution behavior of hydrophobic drugs such as β-lapachone.

摘要

在本研究中,我们旨在设计一种具有高膨胀性和机械强度的骨架片(SMT)作为胃滞留给药系统(GRDDS),以改善低水溶性β-拉帕醌的溶出行为。对于SMT的制备,采用共研磨技术和冻融法分别将β-拉帕醌以无定形状态分散在SMT中,并增强SMT的膨胀和机械性能。结果发现,掺入SMT中的共研磨β-拉帕醌的结晶度显著降低;因此,药物在模拟胃液中的溶出速率可大幅提高。与市售产品相比,β-拉帕醌的SMT还表现出显著增强的膨胀和机械性能。其原因可能是通过冻融法在SMT中形成了具有多孔结构的物理交联聚合物网络。此外,β-拉帕醌在6小时内从SMT中逐渐释放。因此,本研究中开发的β-拉帕醌SMT可作为具有适当膨胀和机械性能的GRDDS,用于改善疏水性药物如β-拉帕醌的溶出行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/ed27bb9bf250/pharmaceutics-11-00271-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/22432ae88d5e/pharmaceutics-11-00271-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/98de654698ae/pharmaceutics-11-00271-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/435cba622713/pharmaceutics-11-00271-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/dbafea723618/pharmaceutics-11-00271-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/32a9622ec927/pharmaceutics-11-00271-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/3b4df8cded61/pharmaceutics-11-00271-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/f7488744b5d2/pharmaceutics-11-00271-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/ed27bb9bf250/pharmaceutics-11-00271-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/22432ae88d5e/pharmaceutics-11-00271-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/98de654698ae/pharmaceutics-11-00271-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/435cba622713/pharmaceutics-11-00271-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/dbafea723618/pharmaceutics-11-00271-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/32a9622ec927/pharmaceutics-11-00271-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/3b4df8cded61/pharmaceutics-11-00271-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/f7488744b5d2/pharmaceutics-11-00271-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f1/6630442/ed27bb9bf250/pharmaceutics-11-00271-g008.jpg

相似文献

1
Mechanically Robust Gastroretentive Drug-Delivery Systems Capable of Controlling Dissolution Behaviors of Coground β-Lapachone.能够控制共研磨β-拉帕醌溶解行为的机械坚固的胃滞留给药系统。
Pharmaceutics. 2019 Jun 10;11(6):271. doi: 10.3390/pharmaceutics11060271.
2
Swelling/floating capability and drug release characterizations of gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose.基于羟乙基纤维素和羧甲基纤维素钠组合的胃滞留给药系统的溶胀/漂浮能力及药物释放特性
PLoS One. 2015 Jan 24;10(1):e0116914. doi: 10.1371/journal.pone.0116914. eCollection 2015.
3
Dissolution improvement of poorly water-soluble drug by cogrinding method using jar mill.采用罐磨机共研磨法提高难溶性药物的溶出度
Pak J Pharm Sci. 2013 May;26(3):495-502.
4
Swellable and porous bilayer tablet for gastroretentive drug delivery: Preparation and in vitro-in vivo evaluation.可溶胀多孔双层片剂用于胃滞留药物递送:制备及体外-体内评价。
Int J Pharm. 2019 Dec 15;572:118783. doi: 10.1016/j.ijpharm.2019.118783. Epub 2019 Oct 31.
5
Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.漂浮型胃滞留药物传递系统:实验与模拟溶出曲线和漂浮行为的比较。
Eur J Pharm Sci. 2014 Jul 16;58:34-43. doi: 10.1016/j.ejps.2014.03.001. Epub 2014 Apr 2.
6
Preparation and Characterization of a Novel Swellable and Floating Gastroretentive Drug Delivery System (sfGRDDS) for Enhanced Oral Bioavailability of Nilotinib.用于提高尼洛替尼口服生物利用度的新型可膨胀漂浮胃滞留药物递送系统(sfGRDDS)的制备与表征
Pharmaceutics. 2020 Feb 6;12(2):137. doi: 10.3390/pharmaceutics12020137.
7
Dissolution enhancement of chlorzoxazone using cogrinding technique.采用共研磨技术提高氯唑沙宗的溶出度
Int J Pharm Investig. 2015 Oct-Dec;5(4):247-58. doi: 10.4103/2230-973X.167689.
8
Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.萘普生-精氨酸-羟丙基-β-环糊精三元体系的固态表征及溶解性能
Eur J Pharm Biopharm. 2005 Jan;59(1):99-106. doi: 10.1016/j.ejpb.2004.05.005.
9
Improvement of dissolution and bioavailability of Ginsenosides by hot melt extrusion and cogrinding.热熔挤出和共研磨法提高人参皂苷的溶出度和生物利用度。
Drug Dev Ind Pharm. 2013 Jan;39(1):109-16. doi: 10.3109/03639045.2012.659189. Epub 2012 Feb 18.
10
Development of a furosemide-containing expandable system for gastric retention.开发一种含呋塞米的可扩张系统用于胃滞留。
J Control Release. 2021 Oct 10;338:105-118. doi: 10.1016/j.jconrel.2021.08.026. Epub 2021 Aug 18.

引用本文的文献

1
In-Depth Study into Polymeric Materials in Low-Density Gastroretentive Formulations.低密度胃滞留制剂中高分子材料的深入研究
Pharmaceutics. 2020 Jul 7;12(7):636. doi: 10.3390/pharmaceutics12070636.

本文引用的文献

1
Current State and Future Perspectives on Gastroretentive Drug Delivery Systems.胃滞留给药系统的现状与未来展望
Pharmaceutics. 2019 Apr 20;11(4):193. doi: 10.3390/pharmaceutics11040193.
2
Interaction Studies Between Levodopa and Different Excipients to Develop Coground Binary Mixtures for Intranasal Application.左旋多巴与不同赋形剂的相互作用研究,以开发用于鼻腔内应用的共研磨二元混合物。
J Pharm Sci. 2019 Aug;108(8):2552-2560. doi: 10.1016/j.xphs.2019.03.005. Epub 2019 Mar 13.
3
Modeling, design and manufacture of innovative floating gastroretentive drug delivery systems based on hot-melt extruded tubes.
基于热熔挤出管的创新型漂浮胃滞留药物输送系统的建模、设计和制造。
Eur J Pharm Biopharm. 2019 Apr;137:196-208. doi: 10.1016/j.ejpb.2019.02.022. Epub 2019 Feb 28.
4
Ziprasidone-loaded arabic gum modified montmorillonite-tailor-made pectin based gastroretentive composites.载齐拉西酮的阿拉伯胶改性蒙脱石-定制果胶基胃滞留复合材料。
Int J Biol Macromol. 2019 May 15;129:552-563. doi: 10.1016/j.ijbiomac.2019.01.171. Epub 2019 Jan 29.
5
Characterization of Xanthan gum-based hydrogel with Fe ions coordination and its reversible sol-gel conversion.具有 Fe 离子配位的黄原胶基水凝胶的特性及其可逆溶胶-凝胶转化。
Carbohydr Polym. 2019 Jan 1;203:139-147. doi: 10.1016/j.carbpol.2018.09.044. Epub 2018 Sep 24.
6
Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles.口服缓释多单元颗粒系统:压制微丸、微粒和纳米粒
Pharmaceutics. 2018 Oct 4;10(4):176. doi: 10.3390/pharmaceutics10040176.
7
Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics.制备和评价含有普瑞巴林的非泡腾型胃滞留片用于每日一次给药和剂量比例药代动力学。
Int J Pharm. 2018 Oct 25;550(1-2):160-169. doi: 10.1016/j.ijpharm.2018.08.038. Epub 2018 Aug 20.
8
Complex Hydrogels Composed of Chitosan with Ring-opened Polyvinyl Pyrrolidone as a Gastroretentive Drug Dosage Form to Enhance the Bioavailability of Bisphosphonates.由壳聚糖与开环聚维酮组成的复杂水凝胶作为胃滞留型药物剂型,以提高双膦酸盐的生物利用度。
Sci Rep. 2018 May 25;8(1):8092. doi: 10.1038/s41598-018-26432-2.
9
Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.胃滞留筏型液体给送系统——一种新的载体介导药物释放延长方法
Drug Deliv. 2018 Nov;25(1):1161-1174. doi: 10.1080/10717544.2018.1474969.
10
Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.通过共晶、无定形固体分散体和晶体固体分散体提高β-拉帕酮(一种难溶性快速结晶剂)的口服生物利用度。
Eur J Pharm Biopharm. 2018 Mar;124:73-81. doi: 10.1016/j.ejpb.2017.12.016. Epub 2018 Jan 2.